ANIP
ANI Pharmaceuticals, Inc.
$75.35
-2.55%
2026-08-21
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Key Fundamentals
P/E Ratio
16.68
Forward P/E
7.26
EPS (TTM)
$4.59
ROE
20.5%
Revenue Growth (YoY)
25.9%
Profit Margin
11.1%
Debt/Equity
104.83
Price/Book
2.75
Beta
0.46
Market Cap
$1.76B
Avg Volume (10D)
474K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$87.19
60D Low
$73.27
Avg Volume
325K
Latest Close
$75.35
Get breakout alerts for ANIP
Sign up for Breakout Scanner to receive daily notifications when ANIP triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
ANI Pharmaceuticals, Inc. (ANIP) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ANIP daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ANIP operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.